These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25368970)

  • 1. Epigenetic test could eliminate repeat biopsies for prostate cancer.
    Printz C
    Cancer; 2014 Nov; 120(22):3428-9. PubMed ID: 25368970
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
    Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
    BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer.
    Resnick MJ; Lee DJ; Magerfleisch L; Vanarsdalen KN; Tomaszewski JE; Wein AJ; Malkowicz SB; Guzzo TJ
    Urology; 2011 Mar; 77(3):548-52. PubMed ID: 21215436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Repeat biopsy of the suspicious prostate cancer: especially the usefulness of MRI].
    Hara T; Yokoyama S; Tsutahara K; Fukuhara S; Mori N; Yamaguchi S; Maejima S; Yoshida S; Adachi S
    Hinyokika Kiyo; 2005 Jun; 51(6):373-6. PubMed ID: 16050474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
    J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma?
    Raviv G; Zlotta AR; Janssen Th; Descamps F; Vanegas JP; Verhest A; Schulman CC
    Cancer; 1996 May; 77(10):2103-8. PubMed ID: 8640677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of percent free prostate specific antigen as a predictor of prostate cancer detection on repeat biopsy.
    Uemura H; Nakamura M; Hasumi H; Sugiura S; Fujinami K; Miyoshi Y; Yao M; Kubota Y
    Int J Urol; 2004 Jul; 11(7):494-500. PubMed ID: 15242358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?
    Ansari MS
    J Urol; 2002 Jul; 168(1):200; author reply 200-1. PubMed ID: 12050532
    [No Abstract]   [Full Text] [Related]  

  • 9. Predicting prostate biopsy result in men with prostate specific antigen 2.0 to 10.0 ng/ml using an investigational prostate cancer methylation assay.
    Baden J; Adams S; Astacio T; Jones J; Markiewicz J; Painter J; Trust C; Wang Y; Green G
    J Urol; 2011 Nov; 186(5):2101-6. PubMed ID: 21944123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat prostate needle biopsy: who needs it?
    Ellis WJ; Brawer MK
    J Urol; 1995 May; 153(5):1496-8. PubMed ID: 7536254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of an increasing prostate-specific antigen level after negative prostate biopsy.
    Shinohara K; Nguyen H; Masic S
    Urol Clin North Am; 2014 May; 41(2):327-38. PubMed ID: 24725493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.
    Lawrentschuk N; Fleshner N
    BJU Int; 2009 Mar; 103(6):730-3. PubMed ID: 19154475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy.
    Lazzeri M; Briganti A; Scattoni V; Lughezzani G; Larcher A; Gadda GM; Lista G; Cestari A; Buffi N; Bini V; Freschi M; Rigatti P; Montorsi F; Guazzoni G
    J Urol; 2012 Oct; 188(4):1137-43. PubMed ID: 22901578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?
    Naya Y; Ayala AG; Tamboli P; Babaian RJ
    Urology; 2004 Mar; 63(3):503-8. PubMed ID: 15028446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat prostate biopsies predict location of index cancer in an active surveillance cohort.
    Tseng KS; Landis P; Brimo F; Partin AW; Epstein JI; Carter HB
    BJU Int; 2011 Nov; 108(9):1415-20. PubMed ID: 21443654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
    Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
    J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].
    Maksimov VA; Kamalov AA; Karpov VK; Riaboĭ AV; Prokhorov AV
    Urologiia; 2001; (2):37-40. PubMed ID: 11490716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values.
    Keetch DW; Catalona WJ
    J Urol; 1995 Nov; 154(5):1795-7. PubMed ID: 7563349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.